Thesis (Ph. D.)--Hong Kong University of Science and Technology, 2002. / Includes bibliographical references (leaves 155-175). Also available in electronic version. Access restricted to campus users.

Dissertation (Ph.D.) --University of Texas Graduate School of Biomedical Sciences at San Antonio, 2008. / Vita. Includes bibliographical references.

Thesis (Ph. D.)--Florida State University, 2006. / Advisor: Debra Ann Fadool, Florida State University, College of Arts and Sciences, Dept. of Biological Science. Title and description from dissertation home page (viewed June 15, 2006). Document formatted into pages; contains xiii, 112 pages. Includes bibliographical references.

Thesis (M.S.) -- Worcester Polytechnic Institute. / Keywords: AP-1; ependymin; neurotrophic factor. Includes bibliographical references (p.63-69).

Thesis (M.Phil.)--Hong Kong University of Science and Technology, 2006. / Includes bibliographical references (leaves 100-121). Also available in electronic version.

Thesis (Ph. D.)--University of Texas at Austin, 2006. / Vita. Includes bibliographical references.

Parkinson’s disease (PD) is among the most devastating neurodegenerative disorders, and affects 1% of the global population above the age of 60. Several mechanisms have been proposed to explain the dopamine degeneration exhibited in PD: mitochondrial dysfunction, and endoplasmic reticulum (ER) stress. Inaccurate diagnosis is one of the greatest challenges to treatment of PD. Currently, there is no standard diagnostic test for PD. Neurotrophic factors (NTF) are secreted proteins that promote survival and maintenance of neurons during development. The loss of NTFs for specific neuronal populations could confer susceptibility to various neurodegenerative disorders. Cerebral dopamine neurotrophic factor (CDNF) is a novel NTF selective for dopamine neurons. CDNF has demonstrated profound neuroprotective and neurorestorative effects on dopamine neurons in well established animal models of PD. Presently, there are no studies examining endogenous levels of CDNF in PD models or clinical populations of PD, prompting the present study. Findings will bring insight into the neurobiological mechanisms underlying neurodegeneration in PD. This study has determined that CDNF protein and mRNA expression is not altered following 6-OHDA lesioning, suggesting a compensatory mechanism of CDNF in response to injury. We have also determined that CDNF mRNA expression declines with age, which could confer susceptibility to developing neurodegenerative diseases such as PD. In clinical populations of PD, platelets showed a significant increase in CDNF mRNA expression that was not seen in lymphocytes or whole blood. This suggests a role of CDNF in PD, specifically for platelets; however, it is important to delineate whether this increase is the result of treatment. Incidentally, we found that CDNF mRNA expression is significantly reduced following stroke. Together, these results stress the importance of CDNF in disorders stemming from ER stress. Future studies should examine the role of CDNF in preclinical models of stroke, as well as knockout models of PD. / Thesis / Master of Science (MSc)

Die retinale in vivo Bildgebung gewann in den letzten 2 Jahrzehnten zunehmend an Bedeutung. Es fehlt aber häufig die Korrelation der in vivo erstellten quasi „histologischen“ Aufnahmen mit der tatsächlichen Histologie. An der Klinik und Poliklinik für Augenheilkunde des Universitätsklinikums Würzburg wurde ein standardisiertes System zur vergleichenden in vivo/ex vivo und histologischen retinalen Bildgebung des menschlichen Auges etabliert. In der vorliegenden „proof of concept study“ konnte der Arbeitsablauf erfolgreich gezeigt werden. Es wurden Abläufe geschaffen, die die ex vivo multimodale retinale Bildgebung analog zur in vivo Bildgebung an denselben Geräten ermöglichen. Die histologische Aufarbeitung des Gewebes erfolgt im Anschluss und ermöglicht die Korrelation von technisch gefundenen Veränderungen mit lichtmikroskopisch beschriebenen Auffälligkeiten. Diese histologischen Korrelate tragen zum besseren Verständnis von in vivo gefundenen Veränderungen bei. Gleichzeitig verbessern neu gefundene Auffälligkeiten in der in vivo Bildgebung das Verständnis und Früherkennung vieler retinaler Erkrankungen. Die Vorteile exzellent konservierter, aufbereiteter und histologisch untersuchter Proben wurde hier am Beispiel der CNTF-Expression dargestellt. Es konnte gezeigt werden, dass dieses Zytokin insbesondere bei neovaskulärer AMD in den Fotorezeptoraußensegmenten exprimiert wird. / Retinal in vivo imaging has become increasingly important over the past two decades. However, there is often no correlation between the almost histological image quality made in vivo and the actual histology. A standardized system for comparing in vivo/ex vivo and histological retinal imaging of the human eye was established at the “Klinik und Poliklinik für Augenheilkunde des Universitätsklinikums Würzburg”. In this "proof of concept study" the workflow could be successfully demonstrated. Procedures were created that enable ex vivo multimodal retinal imaging analogous to in vivo imaging on the same devices. The histological processing of the tissue is then carried out and enables the correlation of technically found changes with abnormalities described by light microscopy. These histological correlations contribute to a better understanding of changes found in vivo. At the same time, newly found abnormalities in in vivo imaging improve the understanding and early detection of many retinal diseases. The advantages of excellently preserved, processed and histologically examined samples were presented here using CNTF expression as an example. It could be shown that this cytokine is expressed in the photoreceptor outer segments, particularly in neovascular AMD.

No description available.

Neurotrophic factors are proteins involved in the maturation, differentiation and survival of neurons. Due to their neuroprotective properties, they have been regarded as potent candidates for the treatment of neurodegenerative diseases. Recently, a novel family of neurotrophic factors was discovered comprising mesencephalic astrocyte-derived neurotrophic factor (MANF) and cerebral dopamine neurotrophic factor (CDNF). These factors have been shown to protect against the degeneration of nigrostriatal dopaminergic neurons in mammalian models of Parkinson's disease, however their neuroprotective mechanisms of action are not yet understood. Although distinct in vertebrates, MANF and CDNF constitute a single homolog in invertebrates. In the present study, we have characterized the in vivo expression and function of the C. elegans homolog manf-1. We have shown that manf-1 is not essential for neuronal development, however when knocked down, mutants exhibit enhanced age-related dopaminergic neuronal degeneration accompanied by an increase in the endogenous ER stress response. Loss of manf-1 function also results in enhanced alpha-synuclein expression and aggregation, a pathological hallmark of Parkinson’s disease. / Thesis / Master of Science (MSc)